Comparison of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (ddC) Versus Ro 31-8959 Plus AZT Plus ddC [clinicaltrials:NCT00001040]
Comparison of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (ddC) Versus Ro 31-8959 Plus AZT Plus ddC [clinicaltrials:NCT00001040]
Bio2RDF identifier
NCT00001040
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00001040
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
PRIMARY: To determine t ...... of
the three regimens.
brief title [clinicaltrials_vocabulary:brief-title]
Comparison of Ro 31-8959 Plus ...... s Ro 31-8959 Plus AZT Plus ddC
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-02T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
AIDS-Related Complex
Acquired Immunodeficiency Syndrome
Drug Therapy, Combination
HIV Protease Inhibitors
Saquinavir
Zalcitabine
Zidovudine
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2011-02-28T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00001040
official title [clinicaltrials_vocabulary:official-title]
Double-Blind, Randomized, Phas ...... s Ro 31-8959 Plus AZT Plus ddC
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
1994-05-01T00:00:00Z
reference [clinicaltrials_vocabulary:reference]
secondary id [clinicaltrials_vocabulary:secondary-id]
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2011-02-01T00:00:00Z
identifier
clinicaltrials:NCT00001040
title
Comparison of Ro 31-8959 Plus ...... s Ro 31-8959 Plus AZT Plus ddC
@en
type
label
Comparison of Ro 31-8959 Plus ...... C [clinicaltrials:NCT00001040]
@en